Compérat et al. review problematic aspects in the pathological assessment of urothelial tumours, evaluating unresolved questions in bladder cancer grading, staging, and tissue handling. They also discuss the incorporation of new molecular and genomic markers into the routine histological work-up.
- Eva Compérat
- Justine Varinot
- Fadi Brimo
